Correction to: Naunyn-Schmiedeberg's Archives of Pharmacology (2022) 395:867–885
10.1007/s00210-022-02250-2
We regret to inform readers that our paper (Kayki-Mutlu et al., 2022) had mistakenly stated that tralokinumab “is administered via weekly subcutaneous injection” (p. 873). This should have read that tralokinumab “is administered as a loading dose, followed by subcutaneous injection every other week”. We apologize for any inconvenience this mistake may have caused.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Gizem Kayki-Mutlu, Email: gkayki@ankara.edu.tr.
Zinnet Sevval Aksoyalp, Email: zinnetsevval.aksoyalp@ikcu.edu.tr.
Leszek Wojnowski, Email: wojnowsk@uni-mainz.de.
Martin C. Michel, Email: marmiche@uni-mainz.de